Tumor samples of BRCA exhibited lower retention of intron 3 in CSF3R (Supplementary Figure S4C), which is a highly mutated oncogene in chronic myeloid leukemia [48,49]. This evidence concerns the gene CSF3R and chronic myelogenous leukemia, BCR-ABL1 positive.